Protocol Ledger

NCT06243458 · Phase II · ACTIVE NOT RECRUITING

RVU120 for Treatment of Anemia in Patients With Lower-risk Myelodysplastic Neoplasms

Interventional Phase II clinical trial protocol NCT06243458 sponsored by GCP-Service International West in Oncology and Hematology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2024-09-10 Enrollment: 41 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT06243458
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)41 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)2 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT06243458
Protocol FieldVerified Registry Value
NCT IdentifierNCT06243458
Consolidated Lead SponsorGCP-Service International West
Therapeutic Condition CohortOncology and Hematology
Clinical Trial PhasePhase II
Overall Recruitment StatusACTIVE NOT RECRUITING
Registered Enrollment41 participants (ACTUAL)
Registered Start Date2024-09-10
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT06243458
Hospital Research SiteLocationSite Profile
Hospital Universitario La PazMadrid, SpainOpen Hospital Dossier ->
Hospital Clínico Universitario de ValenciaValencia, SpainOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI